8-K filing — STERIS plc (STE)
Filed: 2026-10-13 AccNo: 0001193125-26-420487 Size: 191 KB Item 1.01: Entry into a Material Definitive Agreement
Stocks · News reference
Piper Sandler Reiterates Overweight on Steris, Raises Price Target to $275
Piper Sandler analyst Jason Bednar reiterates Steris (NYSE:STE) with a Overweight and raises the price target from $270 to $275.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
STERIS Expands Healthcare Consumables Offering with Definitive Agreement to Acquire Xodus Medical, a Specialty Surgical Products Business Focused on Patient and OR Staff Safety
STERIS plc announced a definitive agreement to acquire Xodus Medical, a specialty surgical products company, for $2.1 billion (net purchase price ~$1.8 billion after tax benefits). The acquisition is expected to close by December 31, 2026, and includes potential earnout consideration up to $150 million. Xodus Medical generated approximately $245 million in annual revenue for 2026 with $135 million in adjusted EBIT. STERIS expects the transaction to be accretive to top-line growth, margins, and adjusted earnings.
STERIS Inks Deal To Acquire Xodus Medical For $2.1B
STERIS plc (NYSE: STE) ("STERIS" or the "Company") today announced that STERIS Corporation, a wholly owned subsidiary of the Company, has signed a definitive agreement to acquire Xodus Medical, Inc., a
China Sterilization Equipment Market Outlook to 2033 - Chemical, Physical and Ultraviolet Sterilizers | Revenue, Volume and Pricing Trends Reveal Growth Opportunities
ResearchAndMarkets.com released a comprehensive market report on China's sterilization equipment industry covering chemical, physical, and ultraviolet sterilizers. The report provides revenue, volume, and pricing data from 2018-2033, competitive analysis of major players, and strategic insights for market entry and expansion in this growing sector.